Literature DB >> 1762306

Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol.

M Rodriguez1, A Martin-Malo, M E Martinez, A Torres, A J Felsenfeld, F Llach.   

Abstract

The calcemic response to parathyroid hormone (PTH) is decreased in renal failure. The reduction of hyperphosphatemia improves the calcemic response to PTH in animals with advanced renal failure. However, since low calcitriol levels in renal failure may also contribute to the decreased calcemic response to PTH, the improved calcemic response observed during the reduction of serum phosphorus may be partially mediated by an increase in serum calcitriol levels. The present study evaluated the calcemic response to PTH in rats with moderate and advanced renal failure and how this response was modified by a high and a low phosphorus diet. In addition, the effect of a change in dietary phosphorus on calcitriol levels was also evaluated. A 48-hour continuous infusion of 1-34 rat PTH increased the serum calcium level to 18.2 +/- 0.4 mg/dl in normal rats, versus 13.7 +/- 0.9 and 12.1 +/- 0.2 mg/dl in rats with moderate and advanced renal failure, respectively. During the PTH infusion, a high phosphorus diet increased the serum phosphorus and resulted in a reduced calcemic response to PTH at each level of renal function; respective serum calcium levels were 13.8 +/- 0.6 mg/dl in normals, 11.2 +/- 0.2 mg/dl in moderate renal failure and 9.6 +/- 0.5 mg/dl in advanced renal failure. In normal rats and in rats with moderate renal failure, dietary phosphorus restriction during the PTH infusion increased serum calcitriol levels. In rats with advanced renal failure, serum calcitriol levels were lower than in the other two groups and were not affected by changes in dietary phosphorus.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1762306     DOI: 10.1038/ki.1991.314

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

Review 1.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

Review 2.  Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies.

Authors:  Mariano Rodríguez Portillo; María E Rodríguez-Ortiz
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

3.  Phosphate administration increases both size and number of parathyroid cells in adult rats.

Authors:  Q Wang; E Paloyan; A M Parfitt
Journal:  Calcif Tissue Int       Date:  1996-01       Impact factor: 4.333

Review 4.  Abnormal skeletal response to parathyroid hormone and the expression of its receptor in chronic uremia.

Authors:  T B Drüeke
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

5.  Clinical impact of hypercalcemia in kidney transplant.

Authors:  Piergiorgio Messa; Cosimo Cafforio; Carlo Alfieri
Journal:  Int J Nephrol       Date:  2011-06-22

6.  Retrospective Study Looking at Cinacalcet in the Management of Hyperparathyroidism after Kidney Transplantation.

Authors:  Habib Mawad; Hugues Bouchard; Duy Tran; Denis Ouimet; Jean-Philippe Lafrance; Robert Zoël Bell; Sarah Bezzaoucha; Anne Boucher; Suzon Collette; Vincent Pichette; Lynne Senécal; Michel Vallée
Journal:  J Transplant       Date:  2017-03-13

7.  Tradeoff-in-the-Nephron: A Theory to Explain the Primacy of Phosphate in the Pathogenesis of Secondary Hyperparathyroidism.

Authors:  Kenneth R Phelps
Journal:  Nutrients       Date:  2017-04-26       Impact factor: 5.717

Review 8.  TGF-Beta Signaling in Bone with Chronic Kidney Disease.

Authors:  Yoshiko Iwasaki; Hideyuki Yamato; Masafumi Fukagawa
Journal:  Int J Mol Sci       Date:  2018-08-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.